Cardinal Health, Inc. (NYSE:CAH – Get Free Report) has been assigned an average rating of “Hold” from the thirteen brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $123.00.
A number of analysts recently weighed in on CAH shares. Barclays upped their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Robert W. Baird upped their price objective on shares of Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a research note on Thursday, August 15th. UBS Group increased their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Argus increased their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a research report on Wednesday, September 11th. Finally, Evercore ISI increased their price target on shares of Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a research report on Thursday, August 15th.
View Our Latest Analysis on CAH
Institutional Investors Weigh In On Cardinal Health
Cardinal Health Stock Performance
Shares of CAH opened at $122.45 on Tuesday. The company’s fifty day moving average is $114.96 and its 200 day moving average is $106.82. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $126.14. The stock has a market capitalization of $29.63 billion, a PE ratio of 23.82, a P/E/G ratio of 1.53 and a beta of 0.60.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The business had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. During the same quarter in the previous year, the business posted $1.73 earnings per share. The business’s revenue was down 4.3% compared to the same quarter last year. As a group, research analysts forecast that Cardinal Health will post 7.82 earnings per share for the current year.
Cardinal Health Cuts Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend is Thursday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.
Cardinal Health Company Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- How to Invest in the Best Canadian StocksĀ
- How to Master Trading Discipline: Overcome Emotional Challenges
- Using the MarketBeat Dividend Tax Calculator
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.